News Archives - Mediprint

MediPrint™ Ophthalmics Announces Initial Series A Funding Success

Plus, Company Comments on Its Poster at Prestigious American Glaucoma

mediprintlens2022-03-16T16:36:22+00:0003.16.2022|

MediPrint™ Ophthalmics Announces Acceptance and Presentation of Poster at the Upcoming GSLS in Las Vegas

Plus, Company Advances Plans for Phase 2b Trial in 2022

mediprintlens2022-03-09T17:02:17+00:0003.09.2022|

MediPrint™ Ophthalmics Announces Promising Results From Its Primary Market Research

Plus, Company Receives Patent for Novel Post-Cataract Surgery Lens SAN

mediprintlens2021-11-04T20:46:59+00:0011.04.2021|

MediPrint featured in Review of Optometry

The Coming Rise of Drug-delivery Contact Lenses This novel new

mediprintlens2021-08-16T16:59:48+00:0008.16.2021|

MediPrint™ Ophthalmics Announces New Corporate Branding and New Website

Plus, Company Spotlights its Successful First-in-human Clinical Study Results

mediprintlens2021-06-08T16:39:48+00:0006.08.2021|

MediPrint™ Ophthalmics Announces Successful Completion of Its SIGHT-1 Phase 2a Clinical Study

First-in-human Trial with Novel Glaucoma Treatment Confirmed Favorable Safety

Michael Jaramillo2021-03-24T16:15:38+00:0003.16.2021|

Leo Lens Pharma Announces A Corporate Name Change To MediPrint™ Ophthalmics

Araceli Richardson2021-03-24T16:08:46+00:0012.08.2020|

Leo Lens Pharma Achieves Two Significant Milestones – FDA IND Submission and Seed Round Fundraising Success

IND Paves the Way to Phase 2a Clinical Study

Araceli Richardson2021-03-24T16:21:17+00:0011.12.2020|

Leo Lens Pharma Expands Its Scientific Advisory Board

External Thought Leaders to Help Guide Progress on Company’s

Araceli Richardson2021-03-31T23:03:25+00:0008.05.2020|

Leo Lens Pharma Excited to be a Presenting Company at OTS 2020

Araceli Richardson2021-03-31T23:07:27+00:0007.17.2020|